Tagged with LG

Bulgaria Vesela Karaivanova, deputy governor at the Bulgarian National Social Security Institute (NSSI), provides a fascinating insight into how the country’s health insurance development has evolved post-communism and the latest movements in one of the fastest improving health services in Europe. Can you briefly introduce to our international audience the cornerstones…

Bulgaria Nikolay Petrov, Bulgaria’s minister of health, explains the five cornerstones of the country’s health strategy moving forward and highlights the role of the Ministry in finding common ground between patients, the industry, healthcare professionals, and the National Health Insurance Fund. What are the cornerstones of the Bulgarian health system and…

Bulgaria Assena Stoimenova, member of the management board of the European Medicines Agency (EMA) and executive director of the Bulgarian Drug Agency (BDA), explains the Agency’s evolution under her tenure as well as her commitment to ensuring that the BDA remains predictable, transparent and fair, being fully focused on safeguarding patients…

Bulgaria Prof. Ilko Getov, PhD, MSc Pharm, MHM, president of the Bulgarian Pharmaceutical Union (BPhU) provides a fascinating insight into the changes sweeping across the pharmaceutical industry in Bulgaria and reveals the country’s determination to modernize its offerings in line with the highest in Europe. Could you please introduce yourself to…

Bulgaria Deyan Denev, Executive Director of the Association of the Research-Based Pharmaceutical Manufacturers in Bulgaria (ARPharM), shares a clear overview of the role of innovative pharmaceutical players within Bulgaria, and the association’s commitment to working with government to enlarge patients’ access to innovative medicines. How has the overall situation for innovative…

Algeria Long considered maladies of affluent urban populations in mature Western economies, non communicable diseases (NCDs)– such as diabetes, cancer, chronic respiratory and cardiovascular diseases – have been spreading silently and unchecked throughout the African continent to the point where they are now reaching epidemic proportions and becoming a major determinant…

Algeria In June 2017, PharmaBoardroom hosted an exclusive round table discussion with key players in Algerian healthcare on the role of health economics and patient data in health policy decision making. The participants were Dr Djaouad Brahim Bourkaib, Director General of Social Security in the Ministry of Labor, Jean-Paul Digy, Vice President for…

Algeria This chart shows how Algeria’s pharmaceuticals and healthcare system has evolved over time; from the creation of the Algerian Central Pharmacy (PCA) back in 1962, all the way to the implementation of the ANPP in 2017. Click here to download the latest roundtable discussion on Algerian healthcare

Algeria Algeria’s key macroeconomic and healthcare indicators. Cardiovascular disease prevalence in North Africa.  Diabetes prevalence in North Africa. The rate of change in the number of years of healthy life lost to obesity in Africa. Click here to download the latest roundtable discussion on Algerian healthcare.

Algeria A high-level civil servant at the ministry for labour explains in depth the social welfare system in Algeria and specifically how pharmaceutical products are registered and the mechanism for state reimbursement of medicines. Can you please start by introducing the social security system in Algeria, highlighting those features that make…

Pharma DHL Supply Chain Benelux understands the challenges life sciences companies face and has developed solutions to help overcome them. The Vice President and Commercial Director discuss how the services of the logistic provider are evolving to better adapt to the new needs of the industry and the business segments offering…

Pharma Pasquale Frega, General Manager for Celgene Italy, discusses the company’s rapid growth and imminent entry into immunology, the business and regulatory environment for innovators in the country and the characteristics of the Italian market that make it especially promising to Celgene. Mr. Frega, to start off, Imnovid, Celgene’s newest oral treatment…